Knotus Co Ltd
KOSDAQ:278650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Knotus Co Ltd
Inventory
Knotus Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Inventory
₩1.5B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Inventory
₩3.1T
|
CAGR 3-Years
10%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Inventory
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Inventory
₩239.8m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
18%
|
CAGR 10-Years
21%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Inventory
₩163.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Inventory
₩160.7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Knotus Co Ltd
Glance View
KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.
See Also
What is Knotus Co Ltd's Inventory?
Inventory
1.5B
KRW
Based on the financial report for Dec 31, 2024, Knotus Co Ltd's Inventory amounts to 1.5B KRW.
What is Knotus Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
7%
Over the last year, the Inventory growth was -3%. The average annual Inventory growth rates for Knotus Co Ltd have been -20% over the past three years , 7% over the past five years .
